SBHMY (Sino Biopharmaceutical) Valuation Rank


SBHMY Sino Biopharmaceutical Ltd SBHMY
88 GF Score
Price $12.68
GF Value $12.81
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Sino Biopharmaceutical Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Sino Biopharmaceutical Valuation Rank Related Terms

SBHMY
88GF Score
Sino Biopharmaceutical Ltd SBHMY
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sino Biopharmaceutical (SBHMY) Overvalued in 2026?

Based on GuruFocus' analysis, Sino Biopharmaceutical stock appears to be undervalued. The current stock price of $12.68 is trading 1% below its estimated GF Value™ of $12.81. GuruFocus considers Sino Biopharmaceutical to be Fairly Valued.

Key valuation signals for SBHMY:

  • Valuation Rank:
  • GF Value™: $12.81 vs. price of $12.68 (1% below fair value)
  • GF Score™: 88/100 with 4 warning signs

No single metric tells the full story. See the SBHMY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sino Biopharmaceutical Business Description

Address 1 Harbour Road, Unit 09, 41st Floor, Office Tower, Room 4109, Convention Plaza, Wanchai, Hong Kong, HKG
Sino Biopharmaceutical Ltd is an investment holding company. The company and its subsidiaries are principally engaged in the research and development, production and sale of a series of pharmaceutical products. Its business covering the entire industrial chain of R&D, production and commercialization of drugs, biological products and high-end generic drugs. The company's therapeutic areas include: oncology, liver disease, respiratory, and surgery/pain relief. The company's revenue was generated from the sale of pharmaceutical products in the Chinese mainland.
88GF Score

Get the complete analysis for SBHMY

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.68
Price
$12.81
GF Value